July 25 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* INSIDE INFORMATION ANNOUNCEMENT RESTRUCTURING OF SUZHOU
FIRST
PHARMA
* COURT RENDERED ITS DECISION TO APPROVE RESTRUCTURING PLAN
AND TO
TERMINATE RESTRUCTURING PROCEEDING
* CREDITORS AT FIRST CREDITORS' MEETING CONVENED ON 16 JUNE
HAVE
APPROVED A PLAN FOR RESTRUCTURING
* IN RESTRUCTURING PLAN, INVESTOR SOLICITED BY ADMINISTRATOR
WILL
PROVIDE RMB355 MILLION TO SUZHOU FIRST PHARMA
* INVESTOR WILL CONTINUE TO DEVELOP EXISTING PRODUCTS OF
SUZHOU
FIRST PHARMA, RESUME PRODUCTION, AMONG OTHERS
* UPON IMPLEMENTATION OF RESTRUCTURING PLAN, SUZHOU FIRST
PHARMA
WILL CEASE TO BE SUBSIDIARY OF COMPANY
* FUNDS TO BE PROVIDED BY INVESTOR UNDER RESTRUCTURING PLAN
WILL
BE UTILIZED TO SETTLE EXISTING DEBTS
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))